Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in laparoscopic major abdominal surgery
NCT04923737Unknown
- Sponsor
- Alexandria University
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in abdominal surgery (2 arms), sponsored by Alexandria University. Primary endpoint: Immune-modulatory effects at 3 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
abdominal surgery
Beyond the preview
Go deeper on NCT04923737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04923737.